Five Prime Therapeutics buy Rathjen
Start price
23.04.17
/
50%
€30.08
Target price
07.11.17
€45.10
Performance (%)
-25.76%
End price
07.11.17
€22.33
Summary
This prediction ended on 07.11.17 with a price of €22.33. The prediction for Five Prime Therapeutics disappointed with a performance of -25.76%. Rathjen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Five Prime Therapeutics | - | - | - | - |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% | 49.549% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% | 85.974% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% | 63.319% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% | 62.380% |
Comments by Rathjen for this prediction
In the thread Five Prime Therapeutics diskutieren
Gute Einstiegschance
Hier könnte charttechnisch ein Boden gefunden werden.
Stopp bei 25,- $
s. a.
https://www.godmode-trader.de/analyse/bb-biotech-q1-zahlen-depot-umschichtungen-die-charttechnik,5269984
(Stop Loss Kurs erreicht)